KPT — KP Tissue Income Statement
0.000.00%
Last trade - 00:00- CA$80.25m
- CA$80.25m
- 26
- 72
- 44
- 45
Annual income statement for KP Tissue, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.794 | 1.12 | -12.5 | -0.83 | 2.49 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.95 | 1.24 | -10.2 | -4.94 | 2.43 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.95 | 1.24 | -10.2 | -4.94 | 2.43 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.95 | 1.24 | -10.2 | -4.94 | 2.43 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.201 | 0.126 | -1.03 | -0.496 | 0.244 |
| Dividends per Share |